Edition:
United Kingdom

ArQule Inc (ARQL.OQ)

ARQL.OQ on NASDAQ Stock Exchange Global Market

5.14USD
21 Mar 2019
Change (% chg)

$0.13 (+2.59%)
Prev Close
$5.01
Open
$5.07
Day's High
$5.16
Day's Low
$4.97
Volume
222,937
Avg. Vol
408,436
52-wk High
$7.21
52-wk Low
$2.23

Chart for

About

ArQule, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics to treat cancers and rare diseases. These drugs focuses on the biological pathways implicated in a range of cancers and certain non-oncology indications. Its clinical-stage pipeline consists of over four drug... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $80.42
Shares Outstanding(Mil.): 71.17
Dividend: --
Yield (%): --

Financials

  ARQL.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -0.39 -- --
ROI: -91.39 8.89 13.82
ROE: -120.33 10.00 15.25

BRIEF-Basilea Announces Collaboration To Study Derazantinib And Atezolizumab In Urothelial Cancer

* BASILEA ANNOUNCES COLLABORATION TO STUDY DERAZANTINIB AND ATEZOLIZUMAB (TECENTRIQ®) IN UROTHELIAL CANCER

24 Jan 2019

Earnings vs. Estimates